NCT02039557

Long Term Follow Up Protocol for NiCord®/CordIn™ (Omidubicel) Patients

Official Title:

Long Term Follow Up for Patients Who Have Received Allogeneic Stem Cell Transplantation of NiCord®/CordIn™, Umbilical Cord Blood-derived Ex Vivo Expanded Stem and Progenitor Cells

Summary

This is an observational study that will monitor clinical outcomes of patients who have received a NiCord®/CordIn™ (omidubicel) transplant as part of a GC clinical interventional study and meet the eligibility criteria for this Long Term Follow Up study.

Eligibility

Inclusion Criteria

* Anyone who has received a NiCord®/CordIn™ (omidubicel) transplant, completed study specific follow up, and has signed the consent for this study.

Exclusion Criteria

* None

Disease(s) and\or Condition(s)

Patients Transplanted With NiCord/CordIn (Omidubicel)

Primary Purpose
Intervention/Treatment
    • Type: GENETIC
    • Name: NiCord®/CordIn™ (omidubicel)
    • Description:
    • Arm Group Labels: NiCord®/CordIn™ (omidubicel) transplanted
Sponsor
  • Gamida Cell ltd